News
Emcutix launches Flawlizo – targeted solutions for quick acne relief: Our Bureau, Mumbai Friday, June 6, 2025, 17:10 Hrs [IST ...
KPRDO vehemently opposes Karnataka Labour dept’s proposed sharp rise in minimum wages: Nandita Vijayasimha, Bengaluru Friday, ...
PCI extends timeline for registration process for ranking and rating of UG, DPharm institutes: GireeshBabu, New Delhi Friday, ...
Innovent Biologics presents data from phase 1 PoC study of IBI363 to treat advanced NSCLC at 2025 ASCO: San Francisco Friday, June 6, 2025, 18:00 Hrs [IST] Innovent Biologics, Inc ...
Our Bureau, Mumbai Friday, June 6, 2025, 17:40 Hrs [IST] ...
Sarepta Therapeutics’ gene therapy to treat limb girdle muscular dystrophy type 2E/R4 gets US FDA platform technology designation: Cambridge, Massachusetts Friday, June 6, 2025, ...
Cellectar’s IopofosineI 131 receives US FDA breakthrough therapy designation for treating Waldenstrom macroglobulinemia: Florham Park, New Jersey Friday, June 6, 2025, 17:00 Hrs ...
Macquarie University study finds Cannabis compounds show promise in killing deadly fungal infections
Macquarie University study finds Cannabis compounds show promise in killing deadly fungal infections: Our Bureau, Bengaluru Friday, June 6, 2025, 16:40 Hrs [IST] Macquarie Univers ...
Tracky unveils India's first bluetooth-connected continuous glucose monitor for preventive healthcare: Our Bureau, Bengaluru Friday, June 6, 2025, 14:45 Hrs [IST] Tracky, a health ...
Veeva Systems & SCRI form collaboration to advance oncology clinical trials: Pleasanton, California Friday, June 6, 2025, 15:00 Hrs [IST] Veeva Systems, a global leader in cloud s ...
Leucine Rich Bio pioneers wellness revolution with microbiome-first approach: Our Bureau, Bengaluru Friday, June 6, 2025, 16:50 Hrs [IST] Leucine Rich Bio, South Asia’s dedicate ...
HIS ASEAN 2025 to make its debut in Kuala Lumpur between June 9 and 11 to discuss Southeast Asia’s medical innovation surge: Our Bureau, Mumbai Friday, June 6, 2025, 14:30 Hrs ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results